Thiazolo-pyramidine / pyridine urea derivatives as adenosine A2B receptor antagonists

Details for Australian Patent Application No. 2007253485 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Brinkman, John A.; Racha, Jagdish Kumar; Qi, Lida; Tan, Jenny; Firooznia, Fariborz; Marcopulos, Nicholas; Cheung, Adrian Wai-Hing; Sarabu, Ramakanth; Guertin, Kevin Richard; Tilley, Jefferson Wright

Agent Spruson & Ferguson

Pub. Number AU-B-2007253485

PCT Pub. Number WO2007/134958

Priority 60/801,481 18.05.06 US

Filing date 8 May 2007

Wipo publication date 29 November 2007

Acceptance publication date 8 July 2010

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/437 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 521/00 (2006.01) Heterocyclic compounds containing unspecified hetero rings

Event Publications

20 November 2008 PCT application entered the National Phase

  PCT publication WO2007/134958 Priority application(s): WO2007/134958

8 July 2010 Application Accepted

  Published as AU-B-2007253485

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007253487-Capsule piercing module

2007253484-Treatment of aqueous suspensions